Vivos Therapeutics VVOS
NASDAQ VVOS
$0.17 -0.01 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vivos Therapeutics (VVOS) Capital Expenditures (QoQ) (2020 - 2026)

Analysis

Vivos Therapeutics (VVOS) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Align Technology 11.30 Bn 10.20 Bn 757.43 Mn
2 Envista Holdings 4.38 Bn 3.26 Bn 407.00 Mn
3 Dentsply Sirona 2.27 Bn 2.03 Bn 493.00 Mn
4 Milestone Scientific 37.81 Mn 35.20 Mn 1.56 Mn
5 Dror Ortho-Design 9.77 Mn 9.68 Mn -
6 Vivos Therapeutics 2.76 Mn 790,007.20 2.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,211.11%
Mar 31, 2026 -99.59%
Dec 31, 2025 5,371.08%
Sep 30, 2025 -110.77%
Jun 30, 2025 531.97%
Mar 31, 2025 -26.06%
Dec 31, 2024 -14.06%
Sep 30, 2024 220.00%
Jun 30, 2024 -60.26%
Mar 31, 2024 -8.48%
Dec 31, 2023 7.14%
Sep 30, 2023 -37.14%
Jun 30, 2023 2.51%
Mar 31, 2023 19.50%
Dec 31, 2022 100.00%
Sep 30, 2022 -80.16%
Jun 30, 2022 320.00%
Mar 31, 2022 -68.59%
Dec 31, 2021 -13.38%
Sep 30, 2021 -66.36%